https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Spatial Genomics and Transcriptomics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

Published : Sep 2022

Report ID: ARC1532

Pages : 250

Format : Spatial Genomics and Transcriptomics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Spatial Genomics & Transcriptomics Market

1.1. Definition and Scope

1.1.1. Definition of Spatial Genomics & Transcriptomics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Spatial Genomics & Transcriptomics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Spatial Genomics & Transcriptomics Market By Product

1.2.3. Spatial Genomics & Transcriptomics Market By Technology

1.2.4. Spatial Genomics & Transcriptomics Market By End-Use

1.2.5. Spatial Genomics & Transcriptomics Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data End-Use

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Spatial Genomics & Transcriptomics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Spatial Genomics & Transcriptomics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Spatial Genomics & Transcriptomics Market By Product

4.1. Introduction

4.2. Spatial Genomics & Transcriptomics Revenue By Product

4.2.1. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast, By Product, 2018-2030

4.2.2. Instruments

4.2.2.1. Instruments Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2. By Type

4.2.2.2.1. By Type Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2.2. IHC

4.2.2.2.2.1. IHC Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2.3. Sequencing Platforms

4.2.2.2.3.1. Sequencing Platforms Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2.4. Mass Spectrometry

4.2.2.2.4.1. Mass Spectrometry Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2.5. Microscopy

4.2.2.2.5.1. Microscopy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2.6. Flow Cytometry

4.2.2.2.6.1. Flow Cytometry Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.2.7. Others

4.2.2.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.3. By Mode

4.2.2.3.1. By Mode Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.3.2. Manual

4.2.2.3.2.1. Manual Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.3.3. Semi-automated

4.2.2.3.3.1. Semi-automated Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.2.3.4. Automated

4.2.2.3.4.1. Automated Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3. Software

4.2.3.1. Software Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3.2. Imaging Tools

4.2.3.2.1. Imaging Tools Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3.3. Bioinformatics Tools

4.2.3.3.1. Bioinformatics Tools Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3.4. Storage and Management Databases

4.2.3.4.1. Storage and Management Databases Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.4. Consumables

4.2.4.1. Consumables Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 5. Spatial Genomics & Transcriptomics Market By Technology

5.1. Introduction

5.2. Spatial Genomics & Transcriptomics Revenue By Technology

5.2.1. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast, By Technology, 2018-2030

5.2.2. Spatial Transcriptomics

5.2.2.1. Spatial Transcriptomics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.2. Sequencing-Based Methods

5.2.2.2.1. Sequencing-Based Methods Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.2.2. In Situ Sequencing

5.2.2.2.2.1. In Situ Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.2.3. Laser Capture Microdissection (LCM)

5.2.2.2.3.1. Laser Capture Microdissection (LCM) Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.2.4. Microtomy Sequencing

5.2.2.2.4.1. Microtomy Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.2.5. Transcriptome In-Vivo Analysis (TIVA)

5.2.2.2.5.1. Transcriptome In-Vivo Analysis (TIVA) Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.3. Microscopy-based RNA Imaging Techniques

5.2.2.3.1. Microscopy-based RNA Imaging Techniques Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.3.2. Padlock Probes/ Rolling Circle Amplification

5.2.2.3.2.1. Padlock Probes/ Rolling Circle Amplification Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.3.3. Single Molecule RNA Fluorescence In-Situ Hybridization

5.2.2.3.3.1. Single Molecule RNA Fluorescence In-Situ Hybridization Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.3.4. Branched DNA Probes

5.2.2.3.4.1. Branched DNA Probes Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.2.4. IHC

5.2.2.4.1. IHC Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3. Spatial Genomics

5.2.3.1. Spatial Genomics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3.2. Microscopy-based Live DNA Imaging

5.2.3.2.1. Microscopy-based Live DNA Imaging Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3.3. FISH

5.2.3.3.1. FISH Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3.4. Massively-Parallel Sequencing

5.2.3.4.1. Massively-Parallel Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3.5. Genome Perturbation Tools

5.2.3.5.1. Genome Perturbation Tools Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3.6. Biochemical Techniques

5.2.3.6.1. Biochemical Techniques Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3.7. Others

5.2.3.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 6. Spatial Genomics & Transcriptomics Market By End-Use

6.1. Introduction

6.2. Spatial Genomics & Transcriptomics Revenue By End-Use

6.2.1. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast, By End-Use, 2018-2030

6.2.2. Pharmaceutical Manufacturer

6.2.2.1. Pharmaceutical Manufacturer Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.3. Academic Customers

6.2.3.1. Academic Customers Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.4. Translational Research

6.2.4.1. Translational Research Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.5. Diagnostic Customers

6.2.5.1. Diagnostic Customers Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Spatial Genomics & Transcriptomics Market By Country 

7.1. North America Spatial Genomics & Transcriptomics Market Overview

7.2. U.S.

7.2.1. U.S. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

7.2.2. U.S. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

7.2.3. U.S. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

7.3. Canada

7.3.1. Canada Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

7.3.2. Canada Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

7.3.3. Canada Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Spatial Genomics & Transcriptomics Market By Country

8.1. Europe Spatial Genomics & Transcriptomics Market Overview

8.2. U.K.

8.2.1. U.K. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

8.2.2. U.K. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

8.2.3. U.K. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.3. Germany

8.3.1. Germany Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

8.3.2. Germany Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

8.3.3. Germany Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.4. France

8.4.1. France Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

8.4.2. France Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

8.4.3. France Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.5. Spain

8.5.1. Spain Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

8.5.2. Spain Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

8.5.3. Spain Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

8.6.2. Rest of Europe Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

8.6.3. Rest of Europe Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Spatial Genomics & Transcriptomics Market By Country

9.1. Asia Pacific Spatial Genomics & Transcriptomics Market Overview

9.2. China

9.2.1. China Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

9.2.2. China Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

9.2.3. China Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.3. Japan

9.3.1. Japan Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

9.3.2. Japan Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

9.3.3. Japan Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.4. India

9.4.1. India Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

9.4.2. India Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

9.4.3. India Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.5. Australia

9.5.1. Australia Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

9.5.2. Australia Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

9.5.3. Australia Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.6. South Korea

9.6.1. South Korea Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

9.6.2. South Korea Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

9.6.3. South Korea Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

9.7.2. Rest of Asia-Pacific Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

9.7.3. Rest of Asia-Pacific Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Spatial Genomics & Transcriptomics Market By Country

10.1. Latin America Spatial Genomics & Transcriptomics Market Overview

10.2. Brazil

10.2.1. Brazil Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

10.2.2. Brazil Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

10.2.3. Brazil Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

10.3. Mexico

10.3.1. Mexico Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

10.3.2. Mexico Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

10.3.3. Mexico Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

10.4.2. Rest of Latin America Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

10.4.3. Rest of Latin America Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Spatial Genomics & Transcriptomics Market By Country 

11.1. Middle East & Africa Spatial Genomics & Transcriptomics Market Overview

11.2. GCC

11.2.1. GCC Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

11.2.2. GCC Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

11.2.3. GCC Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

11.3. South Africa

11.3.1. South Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

11.3.2. South Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

11.3.3. South Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030

11.4.2. Rest of Middle East & Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030

11.4.3. Rest of Middle East & Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Spatial Genomics & Transcriptomics Market

12.1. Spatial Genomics & Transcriptomics Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Spatial Genomics & Transcriptomics Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. NanoString Technologies

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Million), 2021

13.1.3.2. NanoString Technologies 2021 Spatial Genomics & Transcriptomics Business Regional Distribution

13.1.4. Product/Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. 10x Genomics

13.3. CARTANA AB

13.4. Horizon Discovery Group plc

13.5. Illumina, Inc.

13.6. S2 Genomics, Inc.

13.7. Dovetail Genomics

13.8. Seven Bridges Genomic

13.9. Advanced Cell Diagnostics.

Frequently Asked Questions

What is the size of global spatial genomics & transcriptomics market in 2021?

The estimated value of global spatial genomics & transcriptomics market in 2021 was accounted to be USD 184 Million.

What is the CAGR of global spatial genomics & transcriptomics market during forecast period of 2022 to 2030?

The projected CAGR spatial genomics & transcriptomics market during the analysis period of 2022 to 2030 is 8.9%.

Which are the key players operating in the market?

The prominent players of the global spatial genomics & transcriptomics market are NanoString Technologies, 10x Genomics, CARTANA AB, Horizon Discovery Group plc, Illumina, Inc., S2 Genomics, Inc., Dovetail Genomics, Seven Bridges Genomic, and Advanced Cell Diagnostics.

Which region held the dominating position in the global spatial genomics & transcriptomics market?

North America held the dominating spatial genomics & transcriptomics during the analysis period of 2022 to 2030.

Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?

Asia-Pacific region exhibited fastest growing CAGR for spatial genomics & transcriptomics during the analysis period of 2022 to 2030.

What are the current trends and dynamics in the global spatial genomics & transcriptomics market?

Increasing adoption in drug discovery & development, and emergence of novel products, drives the growth of global spatial genomics & transcriptomics market.

By End-Use segment, which sub-segment held the maximum share?

Based on end-use, academic customers segment is expected to hold the maximum share spatial genomics & transcriptomics market.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date